SecBot SecBot
8-K ·Filed Jul 2, 2026

PHGE

BiomX Inc.
BEARISH
Impact 6/10
Horizonweeks Processed4mo ago SEC0001213900-26-075072
8-K material event: Items 4.01
Actionable Insight ▼ Bearish

Auditor change from Big 4 (PwC) to a smaller Israeli firm (Barzily) amid a going-concern qualification is a classic distress signal. Monitor the next 10-Q for any further going-concern deterioration, cash runway disclosures, and potential NYSE American continued listing requirements. The PwC letter agreeing with the statements somewhat mitigates disagreement risk, but the combination of micro-cap status, going-concern warning, and auditor downgrade is bearish.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$0.3190
T+0 close · Jul 2, 2026 · via day close
Latest settled
−40.81%
T+20 · $0.1888
Vs SPY
−40.40%
α at T+20
Next horizon
T+60
due 7w ago
  1. T+0 · Jul 6 $0.3190entry
  2. T+1 · 4mo ago −5.33%α −6.20% · $0.3020
  3. T+5 · 4mo ago −12.23%α −13.16% · $0.2800
  4. T+20 · 4mo ago −40.81%α −40.40% · $0.1888
  5. T+60 · due 7w ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BiomX Inc. (PHGE, $4M market cap) dismissed PwC and engaged Barzily & Co. as its new auditor, effective July 1, 2026. PwC's audit reports for FY2024 and FY2025 included going-concern qualifications, and no disagreements or reportable events were disclosed. While the switch from a Big 4 firm to a smaller Israeli firm is a red flag, the filing states no disagreements and the old auditor agreed with the disclosures, making this a routine change on paper, though the going-concern paragraph amplifies distress risk.

Key Facts

  • PwC (Kesselman & Kesselman) was dismissed as auditor effective July 1, 2026.
  • Barzily & Co. was engaged as the new independent auditor as of July 1, 2026.
  • PwC's audit reports for FY2024 and FY2025 each included a going-concern explanatory paragraph.
  • No disagreements or reportable events occurred between BiomX and PwC during the covered periods.
  • PwC agreed with the company's statements via Exhibit 16.1 letter to the SEC.
  • The company's market cap is approximately $4 million, and it trades on NYSE American.

Financial Impact

No financial figures were provided in the filing; known metrics: market cap ~$4M.

going_concern_risk

Risk Factors

  • Going-concern qualification persists, indicating possible inability to continue operations within 12 months.
  • Downsizing to a smaller auditor may reduce audit quality perception and disadvantage financing efforts.
  • Micro-cap ($4M) suggests limited financial flexibility and high vulnerability to adverse events.
  • NYSE American listing may be at risk if stockholders' equity falls below required minimums.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-075072
Document: ea029693401ex16-1.htm0001213900-26-075072
Document: 0001213900-26-075072-index-headers.html0001213900-26-075072
Document: 0001213900-26-075072-index.html0001213900-26-075072
Document: 0001213900-26-075072.txt0001213900-26-075072

Track record

22 reports on PHGE

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +62.36% at T+20 after the Jun 16, 2026 report. 7 of 11 went positive at some point.

Filters
  1. Oct 7, 20265w ago 8-K Neutral 4/10 Entry $0.3092 to $0.2915 ▼ −5.72% −5.30% vs SPY
  2. Oct 7, 20265w ago DEF 14A Bearish 6/10 Entry $0.3092 to $0.2915 ▲ +5.72% +5.30% vs SPY
  3. Sep 1, 202610w ago 8-K Neutral 3/10 Entry $0.1425 to $0.1421 ▼ −0.28% −1.33% vs SPY
  4. Aug 28, 202611w ago 8-K Neutral 4/10 Entry $0.1371 to $0.1430 ▲ +4.30% +4.99% vs SPY
  5. Aug 5, 202614w ago Press Release Bearish 5/10 Entry $0.1800 to $0.1598 ▲ +11.22% +11.06% vs SPY
  6. Jul 28, 202615w ago 8-K Bearish 8/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
  7. Jul 28, 202615w ago Press Release Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
  8. Jul 27, 202616w ago 424B5 Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
  9. Jul 8, 202618w ago Press Release Neutral 4/10 Entry $0.2758 to $0.2800 ▲ +1.52% +0.68% vs SPY
  10. Jul 2, 202619w ago 8-K Bearish 6/10 Viewing Entry $0.3190 to $0.3020 ▲ +5.33% +6.20% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens in 4h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026